Adapting and validating the Autism Diagnostic Interview - Revised for use with deaf children and young people / B. WRIGHT in Autism, 26-2 (February 2022)  

Public ISBD [article]  inAutism > 26-2 (February 2022) . - p.446-459 Titre : Adapting and validating the Autism Diagnostic Interview - Revised for use with deaf children and young people Type de document : Texte imprimé et/ou numérique Auteurs : B. WRIGHT, Auteur ; H. PHILLIPS, Auteur ; Victoria ALLGAR, Auteur ; J. SWEETMAN, Auteur ; R. HODKINSON, Auteur ; E. HAYWARD, Auteur ; A. RALPH-LEWIS, Auteur ; C. TEIGE, Auteur ; M. BLAND, Auteur ; A. LE COUTEUR, Auteur Article en page(s) : p.446-459 Langues : Anglais (eng) Mots-clés : Autism Diagnostic Interview–Revised  Autism Diagnostic Interview–Revised Deaf Adaptation  British Sign Language  Delphi consensus methodology  autism spectrum disorder  children  deaf  deaf culture  gesture  language  modified Index. décimale : PER Périodiques Résumé : Autism assessment processes need to improve for deaf children as they are currently being diagnosed later than their hearing counterparts and misdiagnosis can occur. We took one of the most commonly used parent developmental interviews for autism spectrum disorder the Autism Diagnostic Interview-Revised and adapted it using international expert advice. Modifications were proposed and agreed by the expert panel for 45% of items; the remaining 55% of items were unchanged. We then tested the revised version, adapted for deaf children (Autism Diagnostic Interview-Revised Deaf Adaptation), in a UK sample of 78 parents/carers of deaf children with autism spectrum disorder and 126 parents/carers with deaf children without autism spectrum disorder. When compared to National Institute for Health and Care Excellence guideline standard clinical assessments, the Autism Diagnostic Interview-Revised Deaf Adaptation diagnostic algorithm threshold scores could identify those deaf children with a definite diagnosis (true autism spectrum disorder positives) well (sensitivity of 89% (79%-96%)) and those deaf children who did not have autism spectrum disorder (true autism spectrum disorder negatives) well (specificity of 81% (70%-89%)). Our findings indicate that the Autism Diagnostic Interview-Revised Deaf Adaptation is likely to prove a useful measure for the assessment of deaf children with suspected autism spectrum disorder and that further research would be helpful. En ligne : http://dx.doi.org/10.1177/13623613211029116 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=452 [article] Adapting and validating the Autism Diagnostic Interview - Revised for use with deaf children and young people [Texte imprimé et/ou numérique] / B. WRIGHT, Auteur ; H. PHILLIPS, Auteur ; Victoria ALLGAR, Auteur ; J. SWEETMAN, Auteur ; R. HODKINSON, Auteur ; E. HAYWARD, Auteur ; A. RALPH-LEWIS, Auteur ; C. TEIGE, Auteur ; M. BLAND, Auteur ; A. LE COUTEUR, Auteur . - p.446-459. Langues : Anglais (eng) in Autism > 26-2 (February 2022) . - p.446-459 Mots-clés : Autism Diagnostic Interview–Revised  Autism Diagnostic Interview–Revised Deaf Adaptation  British Sign Language  Delphi consensus methodology  autism spectrum disorder  children  deaf  deaf culture  gesture  language  modified Index. décimale : PER Périodiques Résumé : Autism assessment processes need to improve for deaf children as they are currently being diagnosed later than their hearing counterparts and misdiagnosis can occur. We took one of the most commonly used parent developmental interviews for autism spectrum disorder the Autism Diagnostic Interview-Revised and adapted it using international expert advice. Modifications were proposed and agreed by the expert panel for 45% of items; the remaining 55% of items were unchanged. We then tested the revised version, adapted for deaf children (Autism Diagnostic Interview-Revised Deaf Adaptation), in a UK sample of 78 parents/carers of deaf children with autism spectrum disorder and 126 parents/carers with deaf children without autism spectrum disorder. When compared to National Institute for Health and Care Excellence guideline standard clinical assessments, the Autism Diagnostic Interview-Revised Deaf Adaptation diagnostic algorithm threshold scores could identify those deaf children with a definite diagnosis (true autism spectrum disorder positives) well (sensitivity of 89% (79%-96%)) and those deaf children who did not have autism spectrum disorder (true autism spectrum disorder negatives) well (specificity of 81% (70%-89%)). Our findings indicate that the Autism Diagnostic Interview-Revised Deaf Adaptation is likely to prove a useful measure for the assessment of deaf children with suspected autism spectrum disorder and that further research would be helpful. En ligne : http://dx.doi.org/10.1177/13623613211029116 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=452

Adapting and validating the Autism Diagnostic Observation Schedule Version 2 for use with deaf children and young people / H. PHILLIPS in Journal of Autism and Developmental Disorders, 52-2 (February 2022)  

Public ISBD [article]  inJournal of Autism and Developmental Disorders > 52-2 (February 2022) . - p.553-568 Titre : Adapting and validating the Autism Diagnostic Observation Schedule Version 2 for use with deaf children and young people Type de document : Texte imprimé et/ou numérique Auteurs : H. PHILLIPS, Auteur ; B. WRIGHT, Auteur ; Victoria ALLGAR, Auteur ; H. MCCONACHIE, Auteur ; J. SWEETMAN, Auteur ; R. HARGATE, Auteur ; R. HODKINSON, Auteur ; M. BLAND, Auteur ; H. GEORGE, Auteur ; A. HUGHES, Auteur ; E. HAYWARD, Auteur ; V. F. G. DE LAS HERAS, Auteur ; A. LE COUTEUR, Auteur Article en page(s) : p.553-568 Langues : Anglais (eng) Mots-clés : Adolescent  Autism Spectrum Disorder/diagnosis  Autistic Disorder  Child  Humans  Sensitivity and Specificity  Specialization  Assessment  Autism Spectrum Disorder  Autism diagnostic observation schedule  Deaf  Delphi consensus  Diagnosis  Sign language  research, authorship, and/or publication of this article. Index. décimale : PER Périodiques Résumé : We report a Delphi Consensus modification and first validation study of the Autism Diagnostic Observation Schedule - 2 with deaf children and young people (ADOS-2 Deaf adaptation). Validation included 122 deaf participants (aged 2-18 years), 63 with an Autism Spectrum Disorder (ASD). This was compared to a National Institute for Health and Clinical Excellence (NICE) guideline standard clinical assessment by blinded independent specialist clinicians. Results showed overall sensitivity 73% (95%CI 60%, 83%); specificity 71% (95%CI 58%, 82%), and for the more common modules 1-3 (combined as in previous studies) sensitivity 79% (95% CI 65-89%); specificity 79% (95% CI 66-89%) suggesting this instrument will be a helpful addition for use with deaf children and young people. En ligne : http://dx.doi.org/10.1007/s10803-021-04931-y Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=455 [article] Adapting and validating the Autism Diagnostic Observation Schedule Version 2 for use with deaf children and young people [Texte imprimé et/ou numérique] / H. PHILLIPS, Auteur ; B. WRIGHT, Auteur ; Victoria ALLGAR, Auteur ; H. MCCONACHIE, Auteur ; J. SWEETMAN, Auteur ; R. HARGATE, Auteur ; R. HODKINSON, Auteur ; M. BLAND, Auteur ; H. GEORGE, Auteur ; A. HUGHES, Auteur ; E. HAYWARD, Auteur ; V. F. G. DE LAS HERAS, Auteur ; A. LE COUTEUR, Auteur . - p.553-568. Langues : Anglais (eng) in Journal of Autism and Developmental Disorders > 52-2 (February 2022) . - p.553-568 Mots-clés : Adolescent  Autism Spectrum Disorder/diagnosis  Autistic Disorder  Child  Humans  Sensitivity and Specificity  Specialization  Assessment  Autism Spectrum Disorder  Autism diagnostic observation schedule  Deaf  Delphi consensus  Diagnosis  Sign language  research, authorship, and/or publication of this article. Index. décimale : PER Périodiques Résumé : We report a Delphi Consensus modification and first validation study of the Autism Diagnostic Observation Schedule - 2 with deaf children and young people (ADOS-2 Deaf adaptation). Validation included 122 deaf participants (aged 2-18 years), 63 with an Autism Spectrum Disorder (ASD). This was compared to a National Institute for Health and Clinical Excellence (NICE) guideline standard clinical assessment by blinded independent specialist clinicians. Results showed overall sensitivity 73% (95%CI 60%, 83%); specificity 71% (95%CI 58%, 82%), and for the more common modules 1-3 (combined as in previous studies) sensitivity 79% (95% CI 65-89%); specificity 79% (95% CI 66-89%) suggesting this instrument will be a helpful addition for use with deaf children and young people. En ligne : http://dx.doi.org/10.1007/s10803-021-04931-y Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=455

Are there more bowel symptoms in children with autism compared to normal children and children with other developmental and neurological disorders?: A case control study / Rachael A. SMITH in Autism, 13-4 (July 2009)  

Public ISBD [article]  inAutism > 13-4 (July 2009) . - p.343-355 Titre : Are there more bowel symptoms in children with autism compared to normal children and children with other developmental and neurological disorders?: A case control study Type de document : Texte imprimé et/ou numérique Auteurs : Rachael A. SMITH, Auteur ; H. FARNWORTH, Auteur ; B. WRIGHT, Auteur ; Victoria ALLGAR, Auteur Année de publication : 2009 Article en page(s) : p.343-355 Langues : Anglais (eng) Mots-clés : autism bowel-disorders faddiness Index. décimale : PER Périodiques Résumé : There is considerable controversy as to whether there is an association between bowel disorders and autism. Using a bowel symptom questionnaire we compared 51 children with autism spectrum disorder with control groups of 35 children from special school and 112 from mainstream school. There was a significant difference in the reporting of certain bowel symptoms (constipation, diarrhoea, flatulence) and food faddiness between the autism group and the mainstream school control group. There was no significant difference between the autism group and children in the special schools except for faddiness, which is an autism specific symptom and not a bowel symptom. This study confirms previously reported findings of an increase in bowel symptoms in children with autism. It would appear, however, that this is not specifically associated with autism as bowel symptoms were reported in similar frequency to a comparison group of children with other developmental and neurological disorders. En ligne : http://dx.doi.org/10.1177/1362361309106418 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=768 [article] Are there more bowel symptoms in children with autism compared to normal children and children with other developmental and neurological disorders?: A case control study [Texte imprimé et/ou numérique] / Rachael A. SMITH, Auteur ; H. FARNWORTH, Auteur ; B. WRIGHT, Auteur ; Victoria ALLGAR, Auteur . - 2009 . - p.343-355. Langues : Anglais (eng) in Autism > 13-4 (July 2009) . - p.343-355 Mots-clés : autism bowel-disorders faddiness Index. décimale : PER Périodiques Résumé : There is considerable controversy as to whether there is an association between bowel disorders and autism. Using a bowel symptom questionnaire we compared 51 children with autism spectrum disorder with control groups of 35 children from special school and 112 from mainstream school. There was a significant difference in the reporting of certain bowel symptoms (constipation, diarrhoea, flatulence) and food faddiness between the autism group and the mainstream school control group. There was no significant difference between the autism group and children in the special schools except for faddiness, which is an autism specific symptom and not a bowel symptom. This study confirms previously reported findings of an increase in bowel symptoms in children with autism. It would appear, however, that this is not specifically associated with autism as bowel symptoms were reported in similar frequency to a comparison group of children with other developmental and neurological disorders. En ligne : http://dx.doi.org/10.1177/1362361309106418 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=768

Melatonin Versus Placebo in Children with Autism Spectrum Conditions and Severe Sleep Problems Not Amenable to Behaviour Management Strategies: A Randomised Controlled Crossover Trial / Barry WRIGHT in Journal of Autism and Developmental Disorders, 41-2 (February 2011)  

Public ISBD [article]  inJournal of Autism and Developmental Disorders > 41-2 (February 2011) . - p.175-184 Titre : Melatonin Versus Placebo in Children with Autism Spectrum Conditions and Severe Sleep Problems Not Amenable to Behaviour Management Strategies: A Randomised Controlled Crossover Trial Type de document : Texte imprimé et/ou numérique Auteurs : Barry WRIGHT, Auteur ; David SIMS, Auteur ; Siobhan SMART, Auteur ; Ahmed ALWAZEER, Auteur ; Ben ALDERSON-DAY, Auteur ; Victoria ALLGAR, Auteur ; Clare WHITTON, Auteur ; Heather TOMLINSON, Auteur ; Sophie D. BENNETT, Auteur ; Jenni JARDINE, Auteur ; Nicola MCAFFREY, Auteur ; Charlotte LEYLAND, Auteur ; Christine JAKEMAN, Auteur ; Jeremy N.V. MILES, Auteur Année de publication : 2011 Article en page(s) : p.175-184 Langues : Anglais (eng) Mots-clés : Melatonin  Sleep  Autism spectrum disorders  Dysomnia Index. décimale : PER Périodiques Résumé : Twenty-two children with autism spectrum disorders who had not responded to supported behaviour management strategies for severe dysomnias entered a double blind, randomised, controlled crossover trial involving 3 months of placebo versus 3 months of melatonin to a maximum dose of 10 mg. 17 children completed the study. There were no significant differences between sleep variables at baseline. Melatonin significantly improved sleep latency (by an average of 47 min) and total sleep (by an average of 52 min) compared to placebo, but not number of night wakenings. The side effect profile was low and not significantly different between the two arms. En ligne : http://dx.doi.org/10.1007/s10803-010-1036-5 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=117 [article] Melatonin Versus Placebo in Children with Autism Spectrum Conditions and Severe Sleep Problems Not Amenable to Behaviour Management Strategies: A Randomised Controlled Crossover Trial [Texte imprimé et/ou numérique] / Barry WRIGHT, Auteur ; David SIMS, Auteur ; Siobhan SMART, Auteur ; Ahmed ALWAZEER, Auteur ; Ben ALDERSON-DAY, Auteur ; Victoria ALLGAR, Auteur ; Clare WHITTON, Auteur ; Heather TOMLINSON, Auteur ; Sophie D. BENNETT, Auteur ; Jenni JARDINE, Auteur ; Nicola MCAFFREY, Auteur ; Charlotte LEYLAND, Auteur ; Christine JAKEMAN, Auteur ; Jeremy N.V. MILES, Auteur . - 2011 . - p.175-184. Langues : Anglais (eng) in Journal of Autism and Developmental Disorders > 41-2 (February 2011) . - p.175-184 Mots-clés : Melatonin  Sleep  Autism spectrum disorders  Dysomnia Index. décimale : PER Périodiques Résumé : Twenty-two children with autism spectrum disorders who had not responded to supported behaviour management strategies for severe dysomnias entered a double blind, randomised, controlled crossover trial involving 3 months of placebo versus 3 months of melatonin to a maximum dose of 10 mg. 17 children completed the study. There were no significant differences between sleep variables at baseline. Melatonin significantly improved sleep latency (by an average of 47 min) and total sleep (by an average of 52 min) compared to placebo, but not number of night wakenings. The side effect profile was low and not significantly different between the two arms. En ligne : http://dx.doi.org/10.1007/s10803-010-1036-5 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=117

---

1 (1 - 4 / 4)